Literature DB >> 12620372

Comparison of the signal transduction pathways for the induction of gene expression of nitric oxide synthase-2 in response to two different stimuli.

Arthur H Neufeld1, Bin Liu.   

Abstract

Human optic nerve astrocytes induce nitric oxide synthase-2 (NOS-2) in vitro in response to cytokines (interferon-gamma/interleukin-1beta) and elevated hydrostatic pressure. Using relatively specific inhibitors, we have compared induction of NOS-2 in response to these two stimuli to determine whether the same or different signal transduction pathways participate in the responses. Using SN50 and CAGE, which inhibit the NFkappaB pathway, the induction of NOS-2 in response to both cytokines and elevated hydrostatic pressure was blocked. Using SB202190 and SB203580, which inhibit p38 mitogen-activated protein kinase, only the response to cytokines was blocked. In contrast, when inhibitors of epidermal growth factor receptor tyrosine kinase AG 82 and AG 18 were used, the induction of NOS-2 in response to pressure, but not in response to cytokines, was blocked. Signal transduction pathways presumably regulate the synthesis of NOS-2 through downstream events that induce transcription of the NOS-2 gene. Our data suggest that activation of different sites in the promoter region of the NOS-2 gene is needed for these different stimuli to induce NOS-2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620372     DOI: 10.1016/s1089-8603(02)00164-7

Source DB:  PubMed          Journal:  Nitric Oxide        ISSN: 1089-8603            Impact factor:   4.427


  2 in total

1.  Pressure activates epidermal growth factor receptor leading to the induction of iNOS via NFkappaB and STAT3 in human proximal tubule cells.

Authors:  Nalini V Broadbelt; Jie Chen; Randi B Silver; Dix P Poppas; Diane Felsen
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-29

2.  Inducible nitric oxide synthase, Nos2, does not mediate optic neuropathy and retinopathy in the DBA/2J glaucoma model.

Authors:  Richard T Libby; Gareth R Howell; Iok-Hou Pang; Olga V Savinova; Adrienne K Mehalow; Joseph W Barter; Richard S Smith; Abbot F Clark; Simon W M John
Journal:  BMC Neurosci       Date:  2007-12-19       Impact factor: 3.288

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.